Related Experiment Videos
Epstein-Barr virus and gastric carcinoma
1Department of Fundamental Health Sciences, School of Nursing and Social Services, Health Sciences University of Hokkaido, Japan.
Seminars in Cancer Biology
|August 1, 1996
Summary
Epstein-Barr virus (EBV) is linked to gastric cancer development. This study found EBV in malignant cells, suggesting its role in tumor formation and immune evasion.
Area of Science:
- Oncology
- Virology
- Gastroenterology
Background:
- Epstein-Barr virus (EBV) is associated with various cancers.
- Its role in gastric cancer, particularly gastric adenocarcinomas, requires further elucidation.
Purpose of the Study:
- To investigate the presence and role of EBV in gastric cancer development.
- To explore the expression of EBV proteins and the host immune response in EBV-positive gastric tumors.
Main Methods:
- Polymerase chain reaction (PCR) and in-situ hybridization were used to detect EBV.
- Expression of EBV nuclear antigen 1 (EBNA1) and latent membrane protein 1 (LMP1) was analyzed.
- EBV antibody titers and T-lymphocyte activity were assessed.
Main Results:
- EBV was detected in lymphoepithelioma-like carcinomas and a subset of gastric adenocarcinomas.
- Malignant cells expressed EBNA1 but not other EBNAs or LMP1.
- Virus-positive tumors showed clonal proliferation, elevated EBV antibody titers, and retained T-lymphocyte activity.
Conclusions:
- EBV is implicated as a contributing factor in gastric cancer development.
- Tumor cells may evade immunosurveillance by expressing only EBNA1.
- EBV infection represents a potential target for gastric cancer prevention or therapy.